Sample Preparation for Quantitative Metal Impurity Testing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Sample Preparation for Quantitative Metal Impurity Testing
The author examines sample-preparations methods used in inductively coupled plasma–optimal emission spectroscopy for four test metals.


Pharmaceutical Technology
Volume 35, pp. s31-s33

Results


Table I: Sample preparation methods using a test article of sodium chloride for testing for arsenic, cadmium, lead, and mercury with an inductively coupled plasma–optical emission spectrometer.
The results are summarized in Tables I and II. Evaluation of the sodium chloride results showed that the indirect solution preparation using closed-vessel microwave digestion gave the best recovery values of the four methods. All four elements met the USP proposed accuracy criterion. The worst of the sample-preparation methods was refluxing. Although sodium chloride is freely soluble in water, the direct aqueous solution method was not the most appropriate for the metals that were analyzed. The cadmium recovery was below 70%.


Table II: Sample preparation methods using a test article of polysorbate 80 for testing for arsenic, cadmium, lead, and mercury with an inductively coupled plasma–optical emission spectrometer.
The polysorbate 80 results showed that no one method gave acceptable recovery for all four metals. The direct aqueous solution was the best method, but had mercury recovery above 150%. The indirect solution preparation using closed-vessel microwave digestion was the second best method, but had mercury recovery slightly below 70%. Mercury recovery may be improved using a stabilizer. The worst of the sample preparation methods was refluxing.

Conclusion

These examples illustrate that solubility of the test article may not be the primary factor when choosing a sample-preparation method. Just because a test article is water soluble, does not mean that the direct aqueous solution method is the best choice. Validation studies need to be performed as described in the USP proposed General Chapter <233> to ensure the method is accurate, specific, precise, and rugged when used as a quantitative method (1).

Gayla Velez is director of analytical laboratory services, SGS Life Science Services, 616 Heathrow Drive, Lincolnshire, IL 60069, tel. 847.821.8900,
.

References

1. USP Proposed General Chapter <233> "Elemental Impurities— Procedures," Pharmacopeial Forum 37 (3), Rev. May 26, 2011, http://www.usppf.com/pf/pub/data/v373/CHA_IPR_373_c233.html#CHA_IPR_373_c23, accessed Aug. 22, 2011.

2. EPA, Method 3050B, "Acid Digestion of Sediments, Sludges, and Soils" (Washington, DC), http://www.epa.gov/osw/hazard/testmethods/sw846/pdfs/3050b.pdf, accessed Aug. 1, 2011.

3. USP 34–NF 29 "USP Purified Water Monograph Water for Pharmaceutical Purposes" (USP, Rockville, MD, 2010), p. 4598.

4. USP, Proposed General Chapter <232>"Elemental Impurities— Limits," Pharmacopeial Forum 37 (3), Rev. May 26, 2011, http://www.usppf.com/pf/pub/data/v373/CHA_IPR_373_c232.html, accessed Aug. 22, 2011.

5. USP 34–NF 29 "Reference Tables: Description and Solubility" (USP, Rockville, MD, 2010), pp. 1035 and 1040.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here